Enterprise Bank & Trust Co Purchases 916 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Enterprise Bank & Trust Co raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,124 shares of the exchange traded fund’s stock after buying an additional 916 shares during the quarter. Enterprise Bank & Trust Co owned about 0.05% of SPDR S&P Biotech ETF worth $2,200,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of XBI. McGuire Investment Group LLC increased its stake in SPDR S&P Biotech ETF by 1.8% in the 4th quarter. McGuire Investment Group LLC now owns 96,439 shares of the exchange traded fund’s stock worth $9,172,000 after acquiring an additional 1,660 shares during the last quarter. Evoke Wealth LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter worth about $51,000. Vista Investment Management increased its stake in SPDR S&P Biotech ETF by 21.2% in the 3rd quarter. Vista Investment Management now owns 11,120 shares of the exchange traded fund’s stock worth $848,000 after acquiring an additional 1,947 shares during the last quarter. Thor Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 3rd quarter worth about $107,000. Finally, Sunbelt Securities Inc. increased its stake in SPDR S&P Biotech ETF by 16.8% in the 3rd quarter. Sunbelt Securities Inc. now owns 3,537 shares of the exchange traded fund’s stock worth $270,000 after acquiring an additional 508 shares during the last quarter.

Shares of XBI traded up $0.15 during midday trading on Tuesday, reaching $94.32. The stock had a trading volume of 3,954,485 shares, compared to its average volume of 4,006,296. The company’s 50-day moving average is $93.92 and its 200 day moving average is $85.34. SPDR S&P Biotech ETF has a 12-month low of $72.97 and a 12-month high of $98.79.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 26th. Stockholders of record on Monday, December 23rd were issued a $0.0009 dividend. This represents a $0.00 dividend on an annualized basis and a dividend yield of 0.00%. The ex-dividend date was Friday, December 20th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: Why do analysts give a neutral rating?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.